Apparatus for treating tissue damage
21 claims: 6 independent, 15 dependent
- 1An apparatus for facilitating the healing of a wound, comprising vacuum means (11,23) for creating a negative pressure on the area of the skin including and surrounding the wound and sealing means (12,20) operatively associated with said vacuum means for maintaining said negative pressure on said wound by contacting the skin surrounding said wound, characterised in that said negative pressure is between about 1.01 and 100.3 kPa (0.01 and 0.99 atmospheres) and in that said apparatus comprises screen means (10,24) for positioning at the wound within the sealing means for preventing overgrowth of tissue at the wound in which said screen means (10,24) comprises an open-cell polymer foam.
- 8An apparatus according in to claim 1 in which the open-cell foam section (10) is configured to overlie the wound, and in which said sealing means (1.2) includes a fluid-impermeable flexible cover overlying said foam section, said cover adapted to form a seal with skin surrounding the wound for maintaining negative pressure beneath said cover, and in which said vacuum means (11) includes a single tubular member having a first end inserted beneath at least a portion of the foam section (10) and having a second end extending from said cover to a location external to said cover for supplying negative pressure beneath the cover.
- 12An apparatus according to any one preceding claim, in which said vacuum means (11,23) includes pump means capable of providing at least 689.5 Pa (0.1 psi) suction.
- 15An apparatus according to any one preceding claim, in which said vacuum means (11,23) operates continuously.
- 20An apparatus according to any one preceding claim wherein said vacuum means (11,23) supplies a negative pressure between about 50,7 and 100,3 kPa (0.5 and 0.99 atmospheres) to the wound.
- 21An apparatus according to any one preceding claim wherein said vacuum means (11,23) supplies a negative pressure between about 50,7 and 81,1 kPa (0.5 and 0.8 atmospheres) to the wound.
Independent claims6
57 paragraphs in 8 sections, as filed
Field of the Invention
This invention relates generally to wound healing, and more specifically is directed to apparatus for treating wounds that are unlikely to heal completely under conventional methods.
Background of the Invention
The treatment of open wounds that are too large to spontaneously close has been a troublesome area for many years. Wound closure requires that epithelial and subcutaneous tissue adjacent to the wound migrate toward and eventually close the wound. Some wounds are sufficiently large or infected that they are unable to close spontaneously. In such instances, a zone of stasis, an area in which localized swelling of tissues restricts the flow of blood to these tissues, forms near the surface of the wound. Without sufficient blood flow, the wound is unable to successfully fight bacterial infection and accordingly is unable to close spontaneously.
The most common technique for closure of open wounds has long been the use of sutures or staples. These mechanical closure methods provide tension on the skin tissue at the wound border that encourages epithelial tissues to migrate toward the wound and cover it. While suturing and stapling of wounds is widely practiced, it has a major drawback: the tensile force required to achieve closure with sutures or staples causes very high localized stresses at the suture insertion points, resulting in the rupture of the tissue at these points. Substantial rupture will eventually cause dehiscence in some wounds, which results in additional tissue loss. Moreover, some infected wounds harden and inflame to such a degree that closure by suturing is not feasible. Wounds not reparable by suturing or stapling generally require prolonged hospitalizations with its attendant high costs, and major surgical procedures, such as grafts of surrounding tissue. Examples of such wounds include large, deep, open wounds, pressure sores resulting from prolonged pressure, ulcers resulting from chronic osteomyelitis, and partial thickness burns that subsequently develop into full thickness burns.
To date, there has been no consistently satisfactory method for treating such wounds. What is needed is a method of closing the wound without the localized stresses that accompany suturing while at the same time treating any infection present in the wound along with a simple apparatus to carry out the method. Such a method and apparatus would reduce hospitalization and increase the probability of wound closure.
WO-A-90/11795 relates to a fluidic connection system for wound drainage or fluid introduction. The device comprises a cover membrane which overlies a wound. The proximate end of a tube fluidically communicates with the wound through an opening in the cover membrane. The device can be operated to evacuate or introduce fluids in either an active or a passive manner. When operated in an active mode, the distal end of the tube is connected to a suction source for draining the wound or to a fluid source for introducing fluid into the wound.
M.E. Chariker et al, in Contemporary Surgery, Vol 34, June 1989, pages 59-63 relates to an apparatus providing closed suction wound drainage.
Summary of the Invention
The invention provides an apparatus for facilitating the healing of a wound according to claim 1. The embodiment of the invention comprises an open-cell polymer foam section configured to overlie a wound, and a flexible tube having an inlet end and an outlet end, said inlet end being inserted into said open cell polymer foam section. A flexible polymer sheet may overly the foam section and tubing and be configured to be adhered to the skin surrounding the wound.
The invention will now be further described, by way of example, with reference to the accompanying drawings, in which:
Brief Description of the Drawings
<ul id="ul0001" list-style="none" compact="compact"><li>Figure 1 shows a cross-sectional view of a negative pressure device comprising a open-cell polymer screen, a flexible hose connecting the foam section to a suction pump, and a flexible polymer sheet overlying the foam-hose assembly to provide the necessary seal; and</li><li>Figure 2 shows a cross-sectional view of a negative pressure device comprising a porous screen, an inflatible cuff attached to a semi-rigid cup, and a flexible hose extending from a suction pump to a point within the sealed volume of the cup-cuff assembly.</li></ul>
Detailed Description of the Invention
The present invention relates to an apparatus for treating tissue damage according to claim 1. Wound closure requires that epithelial and subcutaneous tissue migrate from the wound border toward the wound. The use of negative pressure provides tension on this border tissue that causes accelerated tissue migration. It has been observed that the use of the apparatus also causes within the wound increased formation of granulation tissue, a matrix of collagen, fibronectin, and hyaluronic acid carrying macrophages, fibroblasts, and neovasculature that aids in healing.
Apparatus according to the invention is particularly suited for use on pressure sores. A pressure sore is a wound that develops due to constant compressive pressure on the skin surface and underlying tissue. Blood flow to the compressed tissue is restricted to the extent that the overlying tissue dies and subsequently allows the underlying tissue to become infected. The decrease of blood flow to the wound prevents a normal immune reaction to fight the infection, the presence of which prevents tissue migration from the wound border. Pressure sores often occur on bedridden patients who are unable to feel the sore or to move sufficiently to relieve the contact pressure. Such wounds can become very serious, requiring extensive and repeated skin grafts; some are even fatal. As described above, application of negative pressure to the sore permits migration of wound border tissue to occur and thus allows sores to heal without these more drastic procedures.
The invention can be practiced with the application of substantially continuous negative pressure, where the pressure is relieved only to change the dressing on the wound, or it can be practiced with the use of a cyclic application of pressure in alternate periods of application and non-application. The ratio of duration of application period to non-application period can be as low as 1:10 or as high as 10:1, but is most preferably 1:1. A preferred pattern is 5 minutes of pressure application followed by 5 minutes of relief.
The invention is practiced using a negative pressure ranging from 1.01 and 100.3 kPa (0.01 to 0.99 atmospheres) and more preferably practiced using a negative pressure ranging between 50.7 and 81.1 kPa (0.5 to 0.8 atmospheres). The time period for use of the method on a wound is preferably at least 12 hours, but can be, for example, 1 day, 2 days, 5 days, 7 days, 14 days, 30 days, or even longer. There is no upper limit beyond which use of the method is no longer beneficial; the method increases the rate of closure up to the time the wound actually closes.
Open wounds are almost always contaminated with harmful bacteria. Generally a bacterial density of 10<sup>5</sup> bacterial organisms per gram of tissue is regarded as infected. (It is generally accepted that at this level of infection, grafted tissue will not adhere to a wound). These bacteria must be killed, either through the wound host's natural immune response or through some external method, before a wound will close. We have observed that application of negative pressure to a wound will reduce the bacterial density of the wound; it is believed that this effect is due to either the bacteria's incompatibility with a negative pressure environment or the increased blood flow to the wound area, as blood brings with it cells and enzymes to destroy the bacteria.
The invention can be used to reduce bacterial density in a wound by at least half. More preferably, it can be used to reduce bacterial density by at least 1,000 fold. Most preferably, the method can be used to reduce bacterial density by at least 1,000,000 fold. The ranges of pressure magnitude and application duration are as described above, although Example 3 demonstrates dramatic reduction in wound contamination after a 4-day application of negative pressure. Pressure can be applied continuously or cyclically in the application/nonapplication ratios described above.
The present invention may also be used for treating a burn. A partial thickness burn, one which has a surface layer of dead tissue and an underlying zone of stasis, is often sufficiently infected that it will transform within 24-48 hours into a full thickness burn, one in which all epidermal structures are destroyed. As explained above, the application of a negative pressure to the wound prevents the infection from becoming sufficiently severe to cause destruction of the underlying epidermal structures. As above, the magnitude, pattern, and duration of pressure application can vary with the individual wound.
The present invention also serves to enhance the attachment of living tissue to a wound. Attachment of living tissue to a wound is a common procedure that can take many forms. For example, one common technique is the use of a "flap", a technique in which skin tissue from an area adjacent to the wound is detached on three sides but remains attached on the fourth, then is moved onto the wound. Another frequently used technique is an open skin graft in which skin is fully detached from another skin surface and grafted onto the wound. The application of negative pressure to the wound-graft complex reduces bacterial density in the complex and improves blood flow to the wound, thereby improving the attachment of the grafted tissue.
The acceptable ranges of time, magnitude, and application/non-application ratio are as described above. Each of these variables is affected by the size and type of wound.
Apparatus according to the present invention for facilitating the healing of wounds comprises vacuum means such as a pump for creating a negative pressure on the area of skin surrounding the wound, sealing means such as an adhesive sheet operatively associated with the vacuum means for maintaining negative pressure on the wound by contacting the skin surrounding the wound, and screen means such as an open-cell foam section located within the sealing means for preventing the overgrowth of tissue in the wound area.
The screen means is placed over substantially the expanse of the wound to prevent its overgrowth. The size and configuration of the screen can be adjusted to fit the individual wound. It can be formed from a variety of porous semi-rigid materials. The material must be sufficiently porous to allow oxygen to reach the wound, and sufficiently rigid to prevent wound overgrowth. The screen means comprises an open-cell polymer foam, which permits direct connection of the screen means to the vacuum means through a flexible hose inserted into the foam. Such foam can vary in thickness and rigidity, although it is preferred that a spongy material be used for the patient's comfort if the patient must lay upon the device during its operation. It can also be perforated to reduce its weight. Another embodiment comprises a section of honeycombed polyethylene sheet cut to the shape of the wound.
Possible sealing means include a flexible sealing rim contacting the skin surrounding the wound, a flexible polymer sheet overlying the screen means and the vacuum means and attached to the skin through an adhesive applied to the sheet surface facing the skin, and an inflatable sealing cuff that conforms to the skin when inflated and that is held in place by the suction of the vacuum means. If an adhesive sheet is used, it must have sufficient adhesion to remain in contact with the skin and form a seal under the negative pressure. Additionally, it must be sufficiently flexible to overlay the screen means and still conform to the skin around the wound. The sealing means also can include a semi-rigid cup that protects the wound from external contact. For example, a suitable cup-cuff assembly is provided by an adult CPR mask with an inflatable sleeve.
Suitable vacuum means includes any suction pump capable of providing at least 689.5 Pa (0.1 psi) suction to the wound, and preferably up to 20.7 kPa (3 psi) suction, and most preferably up to 96.5 kPa (14 psi) suction, and a flexible hose that leads from the pump to a point within the pressurized volume created by the sealing means. The pump can be any ordinary suction pump suitable for medical purposes that is capable of providing the necesary suction. The dimension of the tubing are limited only by the pump's ability to provide the suction level neede for operation. A 6.4 mm (1/4 inch) diameter tube has proven suitable. The vacuum means may operate substantially continuously, or may operate cyclically with alternate periods of application and nonapplication of pressure to the wound.
A preferred embodiment of the invention, shown in <b>Figure 1</b>, comprises a substantially flat section of open cell polyester foam section <b>10</b> (Fischer Scientific, Pittsburgh, PA 15219) sufficiently large to cover the wound and thus prevent wound overgrowth, a flexible hollow tube <b>11</b> (Fischer Scientific) inserted into the open cell foam section <b>10</b> and joined thereto with an adhesive and extending to attach at its opposite end to a Cast Vacuum pump (Fischer Scientific), and an loban adhesive sheet <b>12</b> (Minnesota Mining and Manufacturing, St Paul, MN. 55144) overlying the foam section <b>10</b> and tubing <b>11</b> and adhered to the skin surrounding the wound, thus forming a seal that allows creation of a vacuum when the suction pump operates. Such an apparatus would most preferably be packaged in a sterile condition to ameliorate the need for sterilization of the apparatus prior to use (note that the adhesive sheet <b>12</b> could be packaged separately from the foam-tube assembly). A particular advantage of this configuration is its use with pressure sores: the device can be placed in the depths of the wound and the patient can lie upon it without either affecting the utility of the device or further damaging the wound. This becomes critical if the patient cannot be moved from this posture for other medical reasons.
The present invention is explained further in the following examples. These examples are provided for illustrative purposes only and are not to be taken as limiting.
EXAMPLE 1
Rate of Wound Healing under Negative Pressure
This example demonstrates the use of negative pressure to increase the rate of healing of full thickness defects by increasing vascularity and the amount of granulation tissue present.
Fifteen-kilogram pigs were obtained and conditioned for 1 week prior to use. The backs of the pigs were shaved and scrubbed for surgery. Two full thickness circular defects were created on the midline of the animals, 2.5 cm in diameter and 1 cm thick. Alginate impressions were taken of each defect to determine its volume. Cefazolin (Kefzol) (500 mg) was administered intramuscularly (antibiotic). The suction devices used, shown in <b>Figure 2</b>, comprised an adult CPR mask <b>20</b> (Doug Brown and Associates, Huntington Beach, CA 92648) comprising a semi-rigid cup <b>21</b> and inflatible cuff <b>22</b> in contact with the skin, an open cell polyester screen <b>24</b> overlying the wound, and a flexible 6.4 mm (1/4 inch) diameter hose <b>23</b> (Fischer Scientific) connected by a Nalgene tubing connector to a vacuum pump (Fischer Scientific) and extending through a sealed hole in the cup. Each device was configured such that the suction hose ran from the cup on the animal up through a pulley suspended over the center of the pen and down to a vacuum trap bottle to collect any liquid exudate, then down to the vacuum pump. A suction device was attached over each defect, and suction of 13.8 to 41.4 kPa (2-6 psi) was applied to one of the devices. The devices were removed only so that impressions could be made of each defect. This procedure was continued until the volume of both defects was zero.
Table 1 shows data expressed as the amount of granulation tissue formed per day and as the percent difference in rate of granulation tissue formation. The data shows that in all cases the use of negative pressure increased the rate of wound closure and the formation of granulation tissue at a statistically significant rate.
EXAMPLE 2
Rate of Burn Healing under Negative Pressure
This example was designed to demonstrate the use of continuous closed suction for the treatment of deep, partial thickness thermal burns (second degree burns).
The backs of 15 kg pigs were shaved and scrubbed for surgery. A 38 mm (1.5 inch) diameter brass rod was heated to 190°C in an oil bath. The rod was pressed onto the pig's skin for 15 seconds following a well-known technique of relating depth of burn to time and temperature. Three burns were created over the spine of each pig, separated by 5 cm intervals. Suction apparatus cups of the configuration described above were placed over two of the burns, with silver sulphadiazine (Silvadine) cream, the standard antibiotic cream applied to human burns prior to excision of burned tissue, applied to the third. Cefazolin (Kefzol) (500 mg) was administered intramuscularly (antibiotic). Suction of 13.8 to 41.4 kPa (2-6 psi) was applied to one of the cups. A small (2 mm) punch biopsy was taken of the wounded area and examined histologically for depth of burn. <tables id="tabl0001" num="0001"><table frame="all"><title>Table 1</title><tgroup cols="4" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="33mm" colsep="1" /><colspec colnum="2" colname="col2" colwidth="40mm" colsep="1" /><colspec colnum="3" colname="col3" colwidth="40mm" colsep="1" /><colspec colnum="4" colname="col4" colwidth="37mm" colsep="1" /><thead><row><entry namest="col1" nameend="col4" colsep="1" rowsep="1" align="center" valign="top">Rate of granulation tissue formation for control and reduced pressure treated full thickness defects in pigs.</entry></row><row><entry namest="col1" nameend="col1" align="center" valign="top"><b>Animal</b></entry><entry namest="col2" nameend="col2" align="center" valign="top"><b>Granulated Treatment</b></entry><entry namest="col3" nameend="col3" align="center" valign="top"><b>Tissue/Day (cc)</b></entry><entry namest="col4" nameend="col4" align="center" valign="top"><b>% Increase*</b></entry></row></thead><tbody><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">1</entry><entry namest="col2" nameend="col2" align="center" valign="top">Suction</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.48</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46">26.3</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="center" valign="top">Control</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.38</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46" /></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">2</entry><entry namest="col2" nameend="col2" align="center" valign="top">Suction</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">1.16</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46">28.9</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="center" valign="top">Control</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.90</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46" /></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">3</entry><entry namest="col2" nameend="col2" align="center" valign="top">Suction</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.58</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46">75.8</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="center" valign="top">Control</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.33</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46" /></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">4</entry><entry namest="col2" nameend="col2" align="center" valign="top">Suction</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.71</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46">65.1</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="center" valign="top">Control</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.43</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46" /></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">5</entry><entry namest="col2" nameend="col2" align="center" valign="top">Suction</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.71</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46">65.1</entry></row><row><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="center" valign="top">Control</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="42">0.43</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="46" /></row></tbody></tgroup><tgroup cols="4" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm" /><colspec colnum="2" colname="col2" colwidth="40mm" /><colspec colnum="3" colname="col3" colwidth="40mm" /><colspec colnum="4" colname="col4" colwidth="37mm" /><tbody><row><entry namest="col1" nameend="col4" align="justify" valign="top">* (Suction-Control)/Control</entry></row></tbody></tgroup></table></tables><tables id="tabl0002" num="0002"><table frame="all"><title>Table 2</title><tgroup cols="9" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="20mm" colsep="1" /><colspec colnum="2" colname="col2" colwidth="14mm" colsep="1" /><colspec colnum="3" colname="col3" colwidth="13mm" colsep="1" /><colspec colnum="4" colname="col4" colwidth="13mm" colsep="1" /><colspec colnum="5" colname="col5" colwidth="15mm" colsep="1" /><colspec colnum="6" colname="col6" colwidth="13mm" colsep="1" /><colspec colnum="7" colname="col7" colwidth="13mm" colsep="1" /><colspec colnum="8" colname="col8" colwidth="15mm" colsep="1" /><colspec colnum="9" colname="col9" colwidth="15mm" colsep="1" /><thead><row><entry namest="col1" nameend="col9" colsep="1" rowsep="1" align="left" valign="top">Rate of reduction in bacterial density for control and reduce and pressure treated pigs (n=5).</entry></row><row><entry namest="col1" nameend="col1" align="center" valign="top">treatment</entry><entry namest="col2" nameend="col9" colsep="1" rowsep="1" align="center" valign="top"><b>Log Organisms Per Gram Tissue</b></entry></row><row><entry namest="col1" nameend="col1" align="left" valign="top" /><entry namest="col2" nameend="col3" colsep="1" rowsep="1" align="left" valign="top">Day 0</entry><entry namest="col4" nameend="col4" align="center" valign="top">Day 1</entry><entry namest="col5" nameend="col5" align="center" valign="top">Day 2</entry><entry namest="col6" nameend="col6" align="center" valign="top">Day 3</entry><entry namest="col7" nameend="col7" align="center" valign="top">Day 4</entry><entry namest="col8" nameend="col8" align="center" valign="top">Day 5</entry><entry namest="col9" nameend="col9" align="center" valign="top">Day 7</entry></row></thead><tbody><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">control</entry><entry namest="col2" nameend="col2" align="left" valign="top">Mean</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="27">8.44</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="27">8.04</entry><entry namest="col5" nameend="col5" valign="top" align="char" char="." charoff="36">8.17</entry><entry namest="col6" nameend="col6" valign="top" align="char" char="." charoff="27">7.13</entry><entry namest="col7" nameend="col7" valign="top" align="char" char="." charoff="27">7.13</entry><entry namest="col8" nameend="col8" valign="top" align="char" char="." charoff="36">8.82</entry><entry namest="col9" nameend="col9" valign="top" align="char" char="." charoff="36">7.08</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="left" valign="top">SD</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="27">+.38</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="27">±.13</entry><entry namest="col5" nameend="col5" valign="top" align="char" char="." charoff="36">±.98</entry><entry namest="col6" nameend="col6" valign="top" align="char" char="." charoff="27">±.15</entry><entry namest="col7" nameend="col7" valign="top" align="char" char="." charoff="27">±.24</entry><entry namest="col8" nameend="col8" valign="top" align="char" char="." charoff="36">±1.12</entry><entry namest="col9" nameend="col9" valign="top" align="char" char="." charoff="36">±.52</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="center" valign="top">vacuum</entry><entry namest="col2" nameend="col2" align="left" valign="top">Mean</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="27">7.69</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="27">7.36</entry><entry namest="col5" nameend="col5" valign="top" align="char" char="." charoff="36">7.37</entry><entry namest="col6" nameend="col6" valign="top" align="char" char="." charoff="27">6.79</entry><entry namest="col7" nameend="col7" valign="top" align="char" char="." charoff="27">6.43</entry><entry namest="col8" nameend="col8" valign="top" align="char" char="." charoff="36">3.98</entry><entry namest="col9" nameend="col9" valign="top" align="char" char="." charoff="36">4.32</entry></row><row><entry namest="col1" nameend="col1" align="center" valign="top" /><entry namest="col2" nameend="col2" align="left" valign="top">SD</entry><entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="27">±.83</entry><entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="27">±.84</entry><entry namest="col5" nameend="col5" valign="top" align="char" char="." charoff="36">±1.40</entry><entry namest="col6" nameend="col6" valign="top" align="char" char="." charoff="27">±.55</entry><entry namest="col7" nameend="col7" valign="top" align="char" char="." charoff="27">±.45</entry><entry namest="col8" nameend="col8" valign="top" align="char" char="." charoff="36">±3.46</entry><entry namest="col9" nameend="col9" valign="top" align="char" char="." charoff="36">±3.74</entry></row></tbody></tgroup></table></tables>
Biopsies were analyzed by a dermatopathologist who was not told the nature of the study. It was concluded that the suctioned tissue specimens were healthier and healing more quickly than non-suctioned specimens.
EXAMPLE 3
Reduction of Bacterial Density under Negative Pressure
This example illustrates the effects of continuous closed suction on the bacterial density of infected tissue.
Fifteen-kilogram pigs were shaved and prepared for surgery. Two 2.5 cm diameter defects were created on the dorsum of each pig using sterile technique, with a 7.5 cm interval retained between the edges of the defects. Hemostasis was obtained by electrocautery. One ml of culture broth containing 10<sup>8</sup><u style="single">Staph.</u><u style="single">aureus</u> organisms was injected just beneath the surface tissue in the center of each wound. Suction cups of the configuration described above were placed over each defect, and a T-shirt was placed over the animal. Suction of 13.8 to 41.4 kPa (2-6 psi) was applied 24 hours after surgery to only one of the defects, allowing each animal to act as its own control. No antibiotics were given during the course of the study.
Each day, a small (3 mm biopsy punch) piece of granulation tissue was removed from the center of each defect. The number of organisms present in the tissue was determined by weighing the tissue, homogenizing the tissue, serially diluting the supernatant, and plating the diluted supernatant on blood agar plates. Samples of the original broth were treated in an identical manner to determine effects of mechanical manipulations on bacteria viability. The procedure was performed until the wounds were healed.
Table 2 compares the bacterial density of treated wounds and control wounds over time. The data is expressed as the mean log of the number of viable organisms per gram of tissue as a function of time. Clearly, the application of negative pressure increases the rate at which bacteria are destroyed. Using 10<sup>5</sup> organisms per gram of tissue as a baseline for infection, the data show that on average a suctioned wound was disinfected after 4 days of treatment, while the average non-treated wound was still infected after 7 days.
EXAMPLE 4
Treatment of Pressure Sore With Negative Pressure
Mr. LJ. is a 45-year-old diabetic male who has been a paraplegic as the result of a gunshot wound for 12 years. He has a history of recurrent right ischeal fossa pressure sore and right trochanteric pressure ulcer. L.J. was admitted to the hospital for treatment and closure of the pressure sores. A flap was placed onto the wound and secured with sutures and staples.
The incisions of the flap dehisced, resulting in a large, open wound. The tissues of the flap were very edematous and indurated. Nine days after the flap was detached, a negative pressure device was placed over the wound. The device comprised an open-cell polyester foam section (Fischer Scientific) approximately 12.7 mm (1/2 inch) in thickness attached to a suction pump by a flexible hose (Fischer Scientific) and covered and sealed by loban polymer sheet (Minnesota Mining and Manufacturing, St. Paul, MN 55144). A continuous vacuum of 34.5 kPa (5 psi) was applied to the wound. The design of the device allowed the patient to lay comfortably on the device during operation.
The depth of the wound decreased dramatically. The devices were changed and the wound examined on a three times per week basis. Reduced pressure treatment was continued for 6 weeks, at which time the wound was healed.
EXAMPLE 5
Treatment of Pressure Sore With Negative Pressure
Mr. W.E. is a 51-year-old male who had both legs amputated at the hip approximately 20 years ago. He was afflicted with a large pressure sore in the buttocks region. The pressure sore had been present 7 months and measured 200 mm (8 inches) laterally and 76 mm (3 inches) in its greatest width. An open cell foam reduced pressure device as described in Example 4 was placed over the wound and a negative pressure of 34.5 kPa (5 psi) was applied cyclically in alternate periods of 5 minutes on, 5 minutes off. The open cell foam device was used as the patient was lying on the device. The device was changed on a three times per week schedule.
After 5 weeks of treatment, the wound measured 76mm (3 inches) laterally and 38 mm (1.5 inches) at its greatest width. At that point the wound was essentially healthy granulation tissue that accepted a cultured keratinocyte allograft and healed completely.
EXAMPLE 6
Treatment of Wound Dehiscence With Negative Pressure
Mr. C.L. is a 50-year-old male who had undergone a colostomy revision through a midline laparotomy. He was readmitted to the hospital for wound dehiscence and evisceration following forceful coughing. The abdominal wall was closed with Prolene mesh coverage. Six weeks after placement of the Prolene mesh, the wound was still open and measured 28 cm by 23 cm with sparse granulation tissue grown through the Prolene mesh. A large reduced pressure cup device of the type described in Example 1 with an underlying porous Aquaplast sheet (WFR/Aquaplast Corp., Wyckoff, NJ 07481) was placed on the Prolene mesh/wound surface and the space closed with a tent of loban. 34.5 kPa (5 psi) of continuous negative pressure was applied. The device was changed three times per week.
After 6 days, granulation tissue had grown through the Prolene mesh, totally covering the mesh. The patient was taken to the operating room where the surrounding tissue was undermined and grafted onto the wound to partially close the defect. Split thickness skin grafts were used to cover the remainder of the defect, and were placed on the bed of granulation tissue. The wound accepted 80 % of the grafts, and the remaining areas closed with dressing changes alone.
EXAMPLE 7
Treatment of Ankle Osteomyelitic Ulcer With Negative Pressure
Mr. R.F. is a 39-year-old white male who had severe trauma to his left lower extremity secondary to a motor vehicle accident 10 years ago. He had contracted chronic osteomyelitis and an open ulcer with exposed bone of his left lateral ankle (lateral malleolar ulcer). Necrotic soft tissue and bone were surgically removed from the ankle. The patient was placed on a 2-1/2 week course of antibiotics. The day after surgery, a reduced pressure device of the type described in Example 1 was placed over the wound, and a negative pressure of 34.5 kPa (5 psi) was applied. The device was changed on a three times per week schedule. After 14 days of treatment, the wound was smaller and filled with granulation tissue. A split thickness skin graft was placed over the center of the defect and healed primarily.
EXAMPLE 8
Treatment of Burn With Negative Pressure
Patient B. is admitted with second and third degree burns over the face and upper extremities, including both hands, as a result of a house fire. A large mitten-shaped reduced pressure device of the type described in Example 4 is placed over the patient's right hand, with open cell foam inserts placed between the fingers to apply reduced pressure to the interdigit spaces. A vacuum of 20.7 kPa (3 psi) is applied cyclically in a pattern of 5 minutes on, 5 minutes off. The device is changed on a three times per week schedule. Treatment is continued until the necrotic tissue sloughs off or is excised, followed by split thickness skin graft placement.
The foregoing examples are illustrative of the present invention, and are not to be construed as limiting thereof. The invention is defined by the following claims, with equivalents of the claims to be included therein.
Contents8
1 sheet
Sheet 1
Every citation, both waysCites: the store holds 17 of 18
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10105471B2 | Cited by | United States of America | Applicant |
| US12121417B2 | Cited by | United States of America | Applicant |
| US10406036B2 | Cited by | United States of America | Applicant |
| US11141325B2 | Cited by | United States of America | Applicant |
| US10058642B2 | Cited by | United States of America | Applicant |
| US10058642B2 | Cited by | United States of America | Applicant |
| US9814808B2 | Cited by | United States of America | Applicant |
| US12226290B2 | Cited by | United States of America | Applicant |
| US10842919B2 | Cited by | United States of America | Applicant |
| US10130526B2 | Cited by | United States of America | Applicant |
| US10105471B2 | Cited by | United States of America | Applicant |
| US10695469B2 | Cited by | United States of America | Applicant |
| US10010658B2 | Cited by | United States of America | Applicant |
| US12115302B2 | Cited by | United States of America | Applicant |
| US11819386B2 | Cited by | United States of America | Applicant |
| US12458541B2 | Cited by | United States of America | Applicant |
| WO9011759A | Cites | World Intellectual Property Organization (WIPO) | – |
| WO9011795A1 | Cites | World Intellectual Property Organization (WIPO) | – |
| DE561757C | Cites | Germany | – |
| DE847475U | Cites | Germany | – |
| US3026874A | Cites | United States of America | – |
| US3367332A | Cites | United States of America | – |
| US3520300A | Cites | United States of America | – |
| US3568675A | Cites | United States of America | – |
| US3874387A | Cites | United States of America | – |
| US3896810A | Cites | United States of America | – |
| US3954105A | Cites | United States of America | – |
| US4112947A | Cites | United States of America | – |
| US4224945A | Cites | United States of America | – |
| US4250882A | Cites | United States of America | – |
| US4382441A | Cites | United States of America | – |
| US4834110A | Cites | United States of America | – |
| US4969880A | Cites | United States of America | – |
| "Treatment of bone and soft tissue defects in infected nounion", W. Fleischmann et al., Acta Orthopaedica Belgica-Vol. 58, Suppl. I - 1992, pages 227-235 | Non-patent | – | – |
| "BWS, Gefahren und Komplikationen der Therapie", W. Fleischmann et al., OP-JOURNAL. N°3, Jahrgang 6, Dez. 1990, Synthes GmbH, Freiburg | Non-patent | – | – |
| "Wunddrainage in der Elektiv- und Notfallchirurgie: Abdominalchirurgie-Gefässchirurgie-Extremit ätenchirurgie", V. Zumtobel et al., W. Pabst Verlag, 1991, pages 4-16 | Non-patent | – | – |
| "Kunststoff-Taschenbuch", Saechtling, 24th Issue, pages 439, 477 | Non-patent | – | – |
| "Temporärer Hautersatz", W. Mutschler, D.J. Bakker, ZFA 1989, Heft 24, pages 714-720, Sonderdrück | Non-patent | – | – |
| "Vacuum sealing: indication, technique and results", W. Fleischmann et al., European Journal of Orthopaedic Surgery & Traumatology, (1955)-5, pages 37-40 | Non-patent | – | – |
50 members in 13 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 792001 | United States of America | – | |
| 79200191 | United States of America | A | |
| 79200191 | United States of America | A | |
| 9209649 | United States of America | W | |
| 9209649 | United States of America | W | |
| 792001 | – | – | – |
| US19910792001 | – | – | – |
| US1992009649 | – | – | – |
| WO1992US09649 | – | – | – |
Members50
| Document | Office | Kind | |
|---|---|---|---|
| CA2121688A1 | Canada | A1 | |
| WO9309727A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3130393A | Australia | A | |
| CA2157772A1 | Canada | A1 | |
| WO9420041A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6360894A | Australia | A | |
| EP0620720A1 | European Patent Office (EPO) | A1 | |
| EP0620720A4 | European Patent Office (EPO) | A4 | |
| JPH07501958A | Japan | A | |
| EP0688189A1 | European Patent Office (EPO) | A1 | |
| EP0688189A4 | European Patent Office (EPO) | A4 | |
| AU674837B2 | Australia | B2 | |
| JPH09503923A | Japan | A | |
| US5636643A | United States of America | A | |
| US5645081A | United States of America | A | |
| EP0620720B1 | European Patent Office (EPO) | B1 | |
| AT164055T | Austria | T | |
| ATE164055T1 | Austria | T1 | |
| DE69224847D1 | Germany | D1 | |
| ES2114956T3 | Spain | T3 | |
| DE9219136U1 | Germany | U1 | |
| DE69224847T2 | Germany | T2 | |
| AU696031B2 | Australia | B2 | |
| DK0620720T3 | Denmark | T3 | |
| EP0688189B1 | European Patent Office (EPO) | B1 | |
| AT196235T | Austria | T | |
| ATE196235T1 | Austria | T1 | |
| DE69425881D1 | Germany | D1 | |
| DK0688189T3 | Denmark | T3 | |
| ES2151925T3 | Spain | T3 | |
| GR3034817T3 | Greece | T3 | |
| PT688189E | Portugal | E | |
| KR100274726B1 | Republic of Korea | B1 | |
| DE69425881T2 | Germany | T2 | |
| CA2121688C | Canada | C | |
| US2001029956A1 | United States of America | A1 | |
| CA2157772C | Canada | C | |
| EP0688189B2 | European Patent Office (EPO) | B2 | |
| DK0688189T4 | Denmark | T4 | |
| DE69425881T3 | Germany | T3 | |
| ES2151925T5 | Spain | T5 | |
| JP3766934B2 | Japan | B2 | |
| JP3809848B2 | Japan | B2 | |
| US2006213527A1 | United States of America | A1 | |
| EP0620720B2This record | European Patent Office (EPO) | B2 | |
| DK0620720T4 | Denmark | T4 | |
| US7198046B1 | United States of America | B1 | |
| DE69224847T3 | Germany | T3 | |
| US7216651B2 | United States of America | B2 | |
| ES2114956T5 | Spain | T5 |
126 legal events, as 12 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Withdrawal/refusal of revocation action now finalR040 | R040 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Right expiredExpiredMA | MA | GR | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| ExpiryMK07 | MK07 | AT | |
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Discontinued because of reaching the maximum lifetime of a patentV4 | V4 | NL | |
| Ep patent expiredExpiredEUP | EUP | DK | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Patent reinstated in contracting state [announced from national office to epo]PGRI | PGRI | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Re-establishment allowedR074 | R074 | DE | |
| Change of representativeR082 | R082 | DE | |
| Change of representativeR082 | R082 | DE | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Re-establishment allowedR074 | R074 | DE | |
| Internal rectification of the legal status completedR409 | R409 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Patent reinstated in contracting state [announced from national office to epo]PGRI | PGRI | EP | |
| Internal rectification of the legal status completedR409 | R409 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)PATENT REVOKED; PATENTS COURT ON 14 MARCH 2008 REVOKED BY COURT ORDER DATED 12 OCTOBER 2009 (HC08C00744)S72Z | S72Z | GB | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)PATENT REVOKED; APPEAL DATED 9 OCTOBER 2009 (HC08C03563)S72Z | S72Z | GB | |
| Amendment of patent in infringement or revocation proceedings before the court (sect. 75/patents act 1977)PATENT REVOKED; APPLICATION TO AMEND SPECIFICATION UNDER SECTION 75 BEFORE THE COURT FILED ON 4 MARCH 2009 NOT PROCEEDED WITHS75Z | S75Z | GB | |
| Amendment of patent in infringement or revocation proceedings before the court (sect. 75/patents act 1977)APPLICATION OPEN FOR OPPOSITIONS75Z | S75Z | GB | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)APPEAL 2009/0931 DATED 1 MAY 2009 WAS ALLOWED AND CLAIMS 4, 16 & 19 WERE HELD INVALID IN THE ORDER OF THE COURT OFS72Z | S72Z | GB | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)PATENT REVOKED - STAYED PENDING APPEAL; APPEAL DATED 9 OCTOBER 2009 STAYED PENDING APPEAL.(HC08C03563)S72Z | S72Z | GB | |
| Transmission of propertyTP | TP | FR | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)PATENT ARE INVALID.CLAIMS 4, 16 AND 19 OF THES72Z | S72Z | GB | |
| Amendment of patent in infringement or revocation proceedings before the court (sect. 75/patents act 1977)APPLICATION TO AMEND SPECIFICATION UNDER SECTION 75 BEFORE THE COURT FILED ON 4 MARCH 2009, DISMISSED BY COURT ORDER DATED 20 MAY 2009, STAYED PENDING APPEALS75Z | S75Z | GB | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)APPEAL LODGED 1 MAY 2009 AGAINST COURT ORDER DATED 1 MAY 2009 (HC08 C03563)S72Z | S72Z | GB | |
| Claim or counterclaim for revocation before the court (sect. 72 patents act1977)S72Z | S72Z | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20090115 AND 20090121732E | 732E | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Name/firm changedPFA | PFA | CH | |
| Application for revocation before the comptroller (sect. 72/patents act 1977)S72 | S72 | GB | |
| Patent modifiedDC2A | DC2A | ES | |
| Fr: translation filed ** decision concerning oppositionOppositionET3 | ET3 | EP | |
| Nl: receipt of modified translations in the netherlands language after an opposition procedureOppositionNLR3 | NLR3 | EP | |
| Amended ep patent with danish claimsT4 | T4 | DK | |
| Ep patent validated in greeceEP | EP | GR | |
| Ep patent has been republished in amended form after opposition at epoOppositionRPEO | RPEO | SE | |
| Nl: decision of oppositionOppositionNLR2 | NLR2 | EP | |
| Scope or validity of the patent modifiedAUFRECHTERHALTUNG DES PATENTES IN GEAENDERTER FORMAEN | AEN | CH | |
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Information on closure of appeal procedure modifiedAppealORIGINAL CODE: EPIDOSCNOA9OAPAN | APAN | EP | |
| Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU | APBU | EP | |
| Observations filed by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| Observations filed by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| Observations filed by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| Date of receipt of notice of appeal deletedAppealORIGINAL CODE: EPIDOSDNOA2OAPAY | APAY | EP | |
| Appeal reference recordedAppealORIGINAL CODE: EPIDOS REFNAPAA | APAA | EP | |
| Opposition withdrawnWithdrawnORIGINAL CODE: 0009264PLBP | PLBP | EP | |
| Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ | APBQ | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Date of receipt of notice of appeal deletedAppealORIGINAL CODE: EPIDOSDNOA2OAPAY | APAY | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Observations filed by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Opposition filed (corrected)OppositionR26 | R26 | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Nl: opposition has been filed with the epoOppositionNLR1 | NLR1 | EP | |
| Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB | PLAB | EP | |
| Unpublished change to opponent dataORIGINAL CODE: EPIDOS OPPOPLBQ | PLBQ | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Examination of admissibility of oppositionOppositionORIGINAL CODE: EPIDOS OPEXPLAV | PLAV | EP | |
| Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF | PLBF | EP | |
| Examination of admissibility of oppositionOppositionORIGINAL CODE: EPIDOS OPEXPLAV | PLAV | EP | |
| Examination of admissibility of oppositionOppositionORIGINAL CODE: EPIDOS OPEXPLAV | PLAV | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Unpublished change to opponent dataORIGINAL CODE: EPIDOS OPPOPLBQ | PLBQ | EP |
Numbers
- Publication
- 0620720
- Publication, DOCDB
- 0620720
- Publication, EPODOC
- EP0620720
- Application
- 92925128
- Application, DOCDB
- 92925128
- Application, EPODOC
- EP19920925128
Titles3
- German
- VORRICHTUNG ZUM BEHANDELN VON GEWEBESCHÄDEN
- English
- APPARATUS FOR TREATING TISSUE DAMAGE
- French
- APPAREIL SERVANT A TRAITER DES LESIONS TISSULAIRES
Classification
- CPC, 22
- A61M27/00
- A61B17/08
- A61B17/085
- A61B2017/00557
- A61B2017/306
- A61F2013/00174
- A61F2013/00519
- A61F2013/0054
- A61F2013/00919
- A61M1/08
- A61M2205/3379
- A61B2090/401
- A61B90/00
- A61F13/0226
- A61M1/75
- A61M1/78
- A61M1/79
- A61M1/84
- A61M1/96
- A61M1/916
- A61M1/982
- A61F13/05
- IPC, 10
- A61B19 00
- A61B17 00
- A61B17 03
- A61B17 08
- A61B17 30
- A61F13 00
- A61F13 02
- A61M1 00
- A61M1 08
- A61M27 00
Designated states1
- Contracting states, 1
- Sweden
